Clinical Trial Update: Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on maintenance treatment with liposomal doxorubicin (Caelyx) in metastatic breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Drugs mentioned

• Caelyx (liposomal doxorubicin)

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Neoplasms | Phase 4 | Status: COMPLETED